
Ian D. Dang
Examiner (ID: 17375)
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647 |
| Total Applications | 358 |
| Issued Applications | 151 |
| Pending Applications | 21 |
| Abandoned Applications | 186 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7687625
[patent_doc_number] => 20070107073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome'
[patent_app_type] => utility
[patent_app_number] => 10/579744
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 18478
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20070107073.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579744
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579744 | Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome | Nov 18, 2004 | Abandoned |
Array
(
[id] => 7074320
[patent_doc_number] => 20050147588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Methods for treatment of obesity and for promotion of weight loss'
[patent_app_type] => utility
[patent_app_number] => 10/991653
[patent_app_country] => US
[patent_app_date] => 2004-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9442
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20050147588.pdf
[firstpage_image] =>[orig_patent_app_number] => 10991653
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/991653 | Methods for treatment of obesity and for promotion of weight loss | Nov 16, 2004 | Abandoned |
Array
(
[id] => 575700
[patent_doc_number] => 07459523
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-02
[patent_title] => 'Equine P-selectin glycoprotein ligand-1 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/987751
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23463
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/459/07459523.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987751
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987751 | Equine P-selectin glycoprotein ligand-1 and uses thereof | Nov 11, 2004 | Issued |
Array
(
[id] => 5154851
[patent_doc_number] => 20070037734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Process for the purification of il-18 binding protein'
[patent_app_type] => utility
[patent_app_number] => 10/576372
[patent_app_country] => US
[patent_app_date] => 2004-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13691
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037734.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576372
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576372 | Process for the purification of IL-18 binding protein | Nov 3, 2004 | Issued |
Array
(
[id] => 333985
[patent_doc_number] => 07507395
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-24
[patent_title] => 'Methods of using fluorescent pH indicators for intracellular assays'
[patent_app_type] => utility
[patent_app_number] => 10/958670
[patent_app_country] => US
[patent_app_date] => 2004-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9794
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/507/07507395.pdf
[firstpage_image] =>[orig_patent_app_number] => 10958670
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/958670 | Methods of using fluorescent pH indicators for intracellular assays | Oct 3, 2004 | Issued |
Array
(
[id] => 880498
[patent_doc_number] => 07355018
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-08
[patent_title] => 'Modified IGF1 polypeptides with increased stability and potency'
[patent_app_type] => utility
[patent_app_number] => 10/954468
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11714
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/355/07355018.pdf
[firstpage_image] =>[orig_patent_app_number] => 10954468
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/954468 | Modified IGF1 polypeptides with increased stability and potency | Sep 29, 2004 | Issued |
Array
(
[id] => 4681814
[patent_doc_number] => 20080248040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Nucleic Acid Molecules Encoding Novel Human Low-Voltage Activated Calcium Channel Proteins, Designed-Alpha 1I-1 and Alpha 1I-2, Encoded Proteins and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/573764
[patent_app_country] => US
[patent_app_date] => 2004-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 44376
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248040.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573764
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573764 | Nucleic Acid Molecules Encoding Novel Human Low-Voltage Activated Calcium Channel Proteins, Designed-Alpha 1I-1 and Alpha 1I-2, Encoded Proteins and Methods of Use Thereof | Sep 27, 2004 | Abandoned |
Array
(
[id] => 5921388
[patent_doc_number] => 20060240015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Recombinant antibody against human insulin-like growth factor'
[patent_app_type] => utility
[patent_app_number] => 10/573378
[patent_app_country] => US
[patent_app_date] => 2004-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 34714
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240015.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573378
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573378 | Recombinant antibody against human insulin-like growth factor | Sep 23, 2004 | Issued |
Array
(
[id] => 7010775
[patent_doc_number] => 20050064491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Human KCNQ5 potassium channel, methods and compositions thereof'
[patent_app_type] => utility
[patent_app_number] => 10/948493
[patent_app_country] => US
[patent_app_date] => 2004-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 20777
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20050064491.pdf
[firstpage_image] =>[orig_patent_app_number] => 10948493
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/948493 | Human KCNQ5 potassium channel, methods and compositions thereof | Sep 22, 2004 | Abandoned |
Array
(
[id] => 6996261
[patent_doc_number] => 20050136039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Adipocytes and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/946843
[patent_app_country] => US
[patent_app_date] => 2004-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 28844
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136039.pdf
[firstpage_image] =>[orig_patent_app_number] => 10946843
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/946843 | Adipocytes and uses thereof | Sep 21, 2004 | Abandoned |
Array
(
[id] => 7038876
[patent_doc_number] => 20050158310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Methods and compositions for preventing obesity and obesity related disorders'
[patent_app_type] => utility
[patent_app_number] => 10/947555
[patent_app_country] => US
[patent_app_date] => 2004-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 28792
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158310.pdf
[firstpage_image] =>[orig_patent_app_number] => 10947555
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/947555 | Methods and compositions for preventing obesity and obesity related disorders | Sep 21, 2004 | Abandoned |
Array
(
[id] => 7127854
[patent_doc_number] => 20050059598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency'
[patent_app_type] => utility
[patent_app_number] => 10/939111
[patent_app_country] => US
[patent_app_date] => 2004-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21567
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059598.pdf
[firstpage_image] =>[orig_patent_app_number] => 10939111
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/939111 | Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency | Sep 8, 2004 | Issued |
Array
(
[id] => 7083235
[patent_doc_number] => 20050048615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Adipocyte complement related protein zacrp11'
[patent_app_type] => utility
[patent_app_number] => 10/909869
[patent_app_country] => US
[patent_app_date] => 2004-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47895
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048615.pdf
[firstpage_image] =>[orig_patent_app_number] => 10909869
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/909869 | Adipocyte complement related protein zacrp11 | Aug 1, 2004 | Abandoned |
Array
(
[id] => 7202779
[patent_doc_number] => 20050042659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same'
[patent_app_type] => utility
[patent_app_number] => 10/902531
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13561
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042659.pdf
[firstpage_image] =>[orig_patent_app_number] => 10902531
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/902531 | Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same | Jul 28, 2004 | Abandoned |
Array
(
[id] => 7155879
[patent_doc_number] => 20050026836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Composition for the treatment of damaged tissue'
[patent_app_type] => utility
[patent_app_number] => 10/901417
[patent_app_country] => US
[patent_app_date] => 2004-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 167994
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026836.pdf
[firstpage_image] =>[orig_patent_app_number] => 10901417
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/901417 | Composition for the treatment of damaged tissue | Jul 27, 2004 | Abandoned |
Array
(
[id] => 5106628
[patent_doc_number] => 20070065505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form'
[patent_app_type] => utility
[patent_app_number] => 10/564259
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5071
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065505.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564259
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564259 | Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form | Jul 8, 2004 | Abandoned |
Array
(
[id] => 7075494
[patent_doc_number] => 20050148762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Rapid and inexpensive method for the purification of proteorhodopsin'
[patent_app_type] => utility
[patent_app_number] => 10/886782
[patent_app_country] => US
[patent_app_date] => 2004-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5490
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148762.pdf
[firstpage_image] =>[orig_patent_app_number] => 10886782
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/886782 | Rapid and inexpensive method for the purification of proteorhodopsin | Jul 6, 2004 | Issued |
Array
(
[id] => 7159534
[patent_doc_number] => 20050084478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Combination therapy using interferon-tau'
[patent_app_type] => utility
[patent_app_number] => 10/884741
[patent_app_country] => US
[patent_app_date] => 2004-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19083
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084478.pdf
[firstpage_image] =>[orig_patent_app_number] => 10884741
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/884741 | Combination therapy using interferon-tau | Jul 1, 2004 | Abandoned |
Array
(
[id] => 7202945
[patent_doc_number] => 20050042681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Methods and formulations for diagnosing, monitoring, staging and treating heart failure'
[patent_app_type] => utility
[patent_app_number] => 10/877133
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22110
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042681.pdf
[firstpage_image] =>[orig_patent_app_number] => 10877133
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/877133 | Methods and formulations for diagnosing, monitoring, staging and treating heart failure | Jun 24, 2004 | Abandoned |
Array
(
[id] => 5859766
[patent_doc_number] => 20060229243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Aequorin-containing compositions and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 10/872795
[patent_app_country] => US
[patent_app_date] => 2004-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4025
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229243.pdf
[firstpage_image] =>[orig_patent_app_number] => 10872795
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/872795 | Aequorin-containing compositions and methods of using same | Jun 20, 2004 | Abandoned |